1
|
Rajamanickam S, Park JH, Bates K, Timilsina S, Eedunuri VK, Onyeagucha B, Subbarayalu P, Abdelfattah N, Jung KH, Favours E, Mohammad TA, Chen HIH, Vadlamudi RK, Chen Y, Kaipparettu BA, Arbiser JL, Rao MK. Abstract P6-06-04: Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-06-04] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Triple-negative breast cancers (TNBCs) represent aggressive heterogeneous subtype of breast cancer with poor clinical outcome. TNBCs have been reported to have high levels of replication stress due to i) various oncogene activations (C-myc or EGFR) ii) germline BRCA mutations iii) “BRCAness” in the absence of BRCA mutations in sporadic TNBCs. Replication stress is known to cause genomic instability, promote tumorigenesis and plays a critical role in therapy resistance in TNBCs. Therefore, targeting replication stress has emerged as an effective approach for better TNBC treatment through further downregulation of the remaining checkpoints to induce catastrophic failure of TNBC cells proliferation. Herein, we evaluated the anticancer efficacy of Carbazole Blue (CB), a synthetic analogue of Carbazole, on TNBC cells growth and progression. Our results demonstrated that CB inhibits short and long term viability of TNBC (MDA-MB-231, MDA-MB-468 and BT549) cells in a dose dependent manner without affecting normal mammary epithelial (MCF-10A) cells. In addition, CB treatment significantly reduced proliferation of TNBC cells, as evidenced by the BrdU proliferation assay. Consistent with this, our results further demonstrated that CB treatment induced G1/S cell cycle arrest and apoptosis in TNBCs. Importantly, systemic delivery of CB using nanoparticle-based delivery approach suppressed breast cancer growth without inducing toxicity, in preclinical orthotopic xenograft and PDX mouse models of TNBC. Furthermore, our gene microarray analysis revealed that CB treatment modulates the expression and activity of several genes known to be involved in DNA replication (CDC6, CDT1, MCMs, Claspin, POLE and PCNA) and associated DNA repair machinery such as (XRCC3, Exo1 and RAD51), which play pivotal roles in replication stress. Our results for the first time highlight the potential use of CB as a novel and potent therapeutic agent for treating TNBCs. As exploiting replication stress to treat cancer is gaining major interest, compound/s that may induce replication stress and inhibit DNA repair ability of cancer cells, has immense translational potential.
Citation Format: Rajamanickam S, Park JH, Bates K, Timilsina S, Eedunuri VK, Onyeagucha B, Subbarayalu P, Abdelfattah N, Jung KH, Favours E, Mohammad TA, Chen H-IH, Vadlamudi RK, Chen Y, Kaipparettu BA, Arbiser JL, Rao MK. Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-06-04.
Collapse
Affiliation(s)
- S Rajamanickam
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - JH Park
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - K Bates
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - S Timilsina
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - VK Eedunuri
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - B Onyeagucha
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - P Subbarayalu
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - N Abdelfattah
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - KH Jung
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - E Favours
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - TA Mohammad
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - H-IH Chen
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - RK Vadlamudi
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - Y Chen
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - BA Kaipparettu
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - JL Arbiser
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| | - MK Rao
- UT Health San Antonio, San Antonio, TX; Baylor College of Medicine, Houston, TX; Emory University School of Medicine, Atlanta, GA, Ukraine
| |
Collapse
|
2
|
Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, Lanni C, Abdelfattah N, Kuppermann B, Csaky KG, D'Argenio DZ, Burke JA, Hughes PM, Robinson MR. Vitreous VEGF Clearance Is Increased after Vitrectomy. ACTA ACUST UNITED AC 2010; 51:2135-8. [DOI: 10.1167/iovs.09-3582] [Citation(s) in RCA: 81] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Susan S. Lee
- From the Department of Biomedical Engineering, University of Southern California, Los Angeles, California
| | | | | | - Leandro C. Zacharias
- the Department of Ophthalmology, University of California Irvine, Irvine, California; and
| | | | | | | | - Baruch Kuppermann
- the Department of Ophthalmology, University of California Irvine, Irvine, California; and
| | | | - David Z. D'Argenio
- From the Department of Biomedical Engineering, University of Southern California, Los Angeles, California
| | | | | | | |
Collapse
|